COMMUNIQUÉS West-GlobeNewswire

Jay and Silent Bob Enter the Cannabis Products Market -- CFN Media

05/12/2018 - 15:00

SEATTLE, Dec. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Results of Court Meeting and Shire General Meeting

05/12/2018 - 14:35

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION FOR [...]

International Cannabis Corp. Well Positioned in Europe’s Hemp, CBD Markets-- CFN Media

05/12/2018 - 14:30

SEATTLE, Dec. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Enochian Biosciences Announces Uplisting to Nasdaq Under Symbol “ENOB”

05/12/2018 - 14:30

– Appoints former President of GSK Global Vaccine business, Luc Debruyne, to Board of Directors – – Advances ENO-1001 for HIV by entering into research collaboration with Scripps Research – – Enters into agreement with [...]

RECORDATI RECEIVES ORPHAN DRUG DESIGNATION FOR ITS INVESTIGATIONAL TREATMENT FOR NEUROTROPHIC KERATITIS

05/12/2018 - 14:16

RECORDATI RECEIVES ORPHAN DRUG DESIGNATION FOR ITS INVESTIGATIONAL TREATMENT FOR NEUROTROPHIC KERATITIS Milan, 5 December 2018 – Recordati today announced that the FDA has granted Orphan Drug Designation to Recordati [...]

Proposed Combination of Mereo BioPharma and OncoMed Pharmaceuticals

05/12/2018 - 14:10

To be effected by an all-stock transaction plus issuance of Contingent Value Rights (“CVRs”); completion expected H1 2019 Deal broadens asset and shareholder base and extends Enlarged Group cash runway Enlarged Group [...]

Aptinyx to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference

05/12/2018 - 14:07

EVANSTON, Ill., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]

Financial Calendar 2019

05/12/2018 - 14:05

December 5, 2018 Announcement no. 25 Financial Calendar 2019 DATE 2019 DESCRIPTION January 25, 2019 Quiet Period prior to the Annual Report begins (4 weeks) January 10, 2019 Deadline for shareholder proposals - Annual [...]

Evelo Biosciences to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference

05/12/2018 - 14:00

CAMBRIDGE, Mass., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical-stage biotechnology company developing monoclonal microbials to engage immune cells in the small intestine [...]

Kezar Life Sciences to Present at The BMO Prescriptions for Success Healthcare Conference

05/12/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]

Tower One November Update

05/12/2018 - 14:00

VANCOUVER, British Columbia, Dec. 05, 2018 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces it has begun the construction of 60 towers in [...]

Entasis Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference

05/12/2018 - 14:00

WALTHAM, Mass., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Entasis Therapeutics (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced that [...]

Canntab Enters Into a Binding Term Sheet With Leading Orthopaedic Surgeon Dr. Don Garbuz, M.D. for a Clinical Research Trial of Canntab’s Tablets

05/12/2018 - 14:00

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. Partnership formed with Dr. Don Garbuz, an award winning orthopaedic surgeon and medical researcher, credited with over 120 peer reviewed [...]

Replimune to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference

05/12/2018 - 14:00

WOBURN, Mass., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immunotherapies derived from its Immulytic™ platform, today announced that Robert Coffin [...]

Centrexion Therapeutics Announces Completion of Patient Enrollment in Pivotal Phase 3 Clinical Trial of CNTX-4975 for the Treatment of Moderate to Severe Knee Osteoarthritis Pain

05/12/2018 - 13:30

BOSTON, Dec. 05, 2018 (GLOBE NEWSWIRE) -- Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain, today announced completion of [...]

Donald B. Kohn, MD, Orchard Therapeutics Scientific Advisory Board Member, Presents Clinical Proof-of-Concept Data for OTL-102 Gene Therapy for the Treatment of Patients with X-CGD at the Presidential Symposium at the 2018 ASH Annual Meeting

05/12/2018 - 13:30

First demonstration of potential gene therapy treatment in this population leading to sustained levels of functioning neutrophils after 12 months BOSTON and LONDON, Dec. 05, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics [...]

Conatus Announces Results from ENCORE-PH Phase 2b Clinical Trial in NASH Cirrhosis

05/12/2018 - 13:30

- Clinically Meaningful Improvements in Portal Hypertension in High Risk Compensated Cirrhosis Patients - - Conference Call and Webcast Presentation at 8:30 a.m. ET Today - SAN DIEGO, Dec. 05, 2018 (GLOBE NEWSWIRE) -- [...]

Cytokinetics Announces Initiation of Phase 1 Clinical Trial of CK-3773274, a Cardiac Myosin Inhibitor

05/12/2018 - 13:30

SOUTH SAN FRANCISCO, Calif., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the first subject has been dosed in a Phase 1 double-blind, randomized, placebo-controlled, multi- [...]

IMV Welcomes Marc Jasmin as Senior Director, Investor Relations and Communications

05/12/2018 - 13:05

DARTMOUTH, Nova Scotia, Dec. 05, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that Marc Jasmin has joined the Company in the newly created role [...]